People · Operator

EDWIN SHEETZ

Named in public records as an officer, director or promoter · active 2024–2024 · Healthtech

1
Companies
1
Filings
$49.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Palo Alto Health Sciences, Inc.HealthtechSeries B$49.6M$166.2M2024
Operator network

EDWIN SHEETZ at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Stephen Bruso · 9 companies · 1 sharedStephen BrusoNed Scheetz · 8 companies · 1 sharedNed ScheetzJonathan MacQuitty · 7 companies · 1 sharedJonathan MacQuittyRussell Siegelman · 5 companies · 1 sharedRussell SiegelmanEdwin F. Scheetz · 3 companies · 1 sharedEdwin F. ScheetzDebra Reisenthel · 2 companies · 1 sharedDebra ReisenthelSIMON THOMAS · 2 companies · 1 sharedSIMON THOMASSteve Schwartz · 2 companies · 1 sharedSteve SchwartzAmy F. Perry · 1 companies · 1 sharedAmy F. PerryDean F. Sawyer · 1 companies · 1 sharedDean F. SawyerElizabeth Siegelman · 1 companies · 1 sharedElizabeth Siegelm…Jonathan F. MacQuitty · 1 companies · 1 sharedJonathan F. MacQu…JOSEPH PEREKUPKA · 1 companies · 1 sharedJOSEPH PEREKUPKASimon F. Thomas · 1 companies · 1 sharedSimon F. ThomasPalo Alto Health Sciences, Inc. · $49.6M raisedPalo Alto Health Scie…EDWIN SHEETZES
EDWIN SHEETZ Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside EDWIN SHEETZ on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Stephen Bruso19
Ned Scheetz18
Jonathan MacQuitty17
Russell Siegelman15
Edwin F. Scheetz13
Steve Schwartz12
Debra Reisenthel12
SIMON THOMAS12
Jonathan F. MacQuitty11
JOSEPH PEREKUPKA11
Dean F. Sawyer11
Simon F. Thomas11
Amy F. Perry11
Elizabeth Siegelman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.